Intraday BUY SELL Signals
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
CURE vs TMO
CURE vs TMO Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CURE vs. TMO commentary
Dec 29, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and TMO is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
TMO: Fundamental Ratings
TMO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 69 | |
SMR RATING 1..100 | 59 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 47 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| CURE | TMO | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 41% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 55% |
| Momentum ODDS (%) | 3 days ago 87% | 3 days ago 66% |
| MACD ODDS (%) | 3 days ago 86% | 3 days ago 58% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 62% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 63% |
| Advances ODDS (%) | 3 days ago 90% | 6 days ago 61% |
| Declines ODDS (%) | 12 days ago 90% | 11 days ago 62% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 55% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 62% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LDEM | 58.53 | 0.15 | +0.26% |
| iShares® ESG MSCI EM Leaders ETF | |||
| IVAL | 31.55 | 0.04 | +0.11% |
| Alpha Architect Intl Quant Val ETF | |||
| JEPQ | 59.34 | 0.05 | +0.08% |
| JPMorgan Nasdaq Equity Premium Inc ETF | |||
| SPBW | 27.47 | 0.01 | +0.04% |
| AllianzIM Buffer20 Allocation ETF | |||
| EWS | 27.55 | N/A | N/A |
| iShares MSCI Singapore ETF | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +0.28% | ||
| TMO - CURE | 72% Closely correlated | +0.28% | ||
| IQV - CURE | 71% Closely correlated | +0.40% | ||
| A - CURE | 68% Closely correlated | +0.05% | ||
| PFE - CURE | 68% Closely correlated | +0.24% | ||
| MTD - CURE | 67% Closely correlated | +0.21% | ||
More | ||||
TMO and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y